People's United Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.89M | Sell |
14,490
-37,307
| -72% | -$4.86M | 0.05% | 230 |
|
|
2021
Q4 | $7.91M | Sell |
51,797
-40,875
| -44% | -$6.33M | 0.19% | 125 |
|
|
2021
Q3 | $15M | Sell |
92,672
-1,870
| -2% | -$315K | 0.33% | 80 |
|
|
2021
Q2 | $15.5M | Sell |
94,542
-1,638
| -2% | -$252K | 0.35% | 79 |
|
|
2021
Q1 | $14.5M | Sell |
96,180
-740
| -0.8% | -$118K | 0.35% | 77 |
|
|
2020
Q4 | $14.7M | Sell |
96,920
-1,432
| -1% | -$205K | 0.36% | 76 |
|
|
2020
Q3 | $13.3M | Buy |
98,352
+1,213
| +1% | +$165K | 0.37% | 74 |
|
|
2020
Q2 | $13.3M | Buy |
97,139
+10,435
| +12% | +$1.33M | 0.39% | 74 |
|
|
2020
Q1 | $9.34M | Sell |
86,704
-439
| -0.5% | -$50.5K | 0.32% | 83 |
|
|
2019
Q4 | $10.5M | Sell |
87,143
-4,057
| -4% | -$453K | 0.29% | 90 |
|
|
2019
Q3 | $9.07M | Sell |
91,200
-8,404
| -8% | -$880K | 0.26% | 92 |
|
|
2019
Q2 | $10.9M | Sell |
99,604
-3,164
| -3% | -$337K | 0.3% | 80 |
|
|
2019
Q1 | $11.5M | Buy |
102,768
+4,680
| +5% | +$513K | 0.36% | 69 |
|
|
2018
Q4 | $9.46M | Buy |
98,088
+2,394
| +3% | +$254K | 0.33% | 76 |
|
|
2018
Q3 | $11.7M | Buy |
95,694
+24,389
| +34% | +$2.87M | 0.36% | 67 |
|
|
2018
Q2 | $7.83M | Buy |
71,305
+7,601
| +12% | +$813K | 0.2% | 140 |
|
|
2018
Q1 | $6.8M | Buy |
63,704
+37,872
| +147% | +$4.2M | 0.22% | 107 |
|
|
2017
Q4 | $2.76M | Buy |
+25,832
| New | +$2.76M | 0.09% | 190 |
|
|
2017
Q3 | – | Sell |
-20,520
| Closed | -$2.12M | – | 698 |
|
|
2017
Q2 | $2.12M | Sell |
20,520
-345
| -2% | -$34K | 0.07% | 214 |
|
|
2017
Q1 | $2.04M | Sell |
20,865
-2,994
| -13% | -$287K | 0.07% | 215 |
|
|
2016
Q4 | $2.11M | Sell |
23,859
-90
| -0.4% | -$8.19K | 0.08% | 196 |
|
|
2016
Q3 | $2.31M | Sell |
23,949
-60
| -0.2% | -$5.71K | 0.12% | 138 |
|
|
2016
Q2 | $2.06M | Sell |
24,009
-2,265
| -9% | -$203K | 0.11% | 144 |
|
|
2016
Q1 | $2.28M | Sell |
26,274
-2,226
| -8% | -$199K | 0.12% | 145 |
|
|
2015
Q4 | $3.21M | Buy |
28,500
+2,151
| +8% | +$233K | 0.17% | 117 |
|
|
2015
Q3 | $2.66M | Sell |
26,349
-36
| -0.1% | -$4.32K | 0.15% | 134 |
|
|
2015
Q2 | $3.25M | Sell |
26,385
-6,810
| -21% | -$815K | 0.17% | 124 |
|
|
2015
Q1 | $3.8M | Buy |
33,195
+9,300
| +39% | +$1.03M | 0.19% | 116 |
|
|
2014
Q4 | $2.42M | Sell |
23,895
-105
| -0.4% | -$10.2K | 0.12% | 150 |
|
|
2014
Q3 | $2.19M | Sell |
24,000
-2,550
| -10% | -$224K | 0.12% | 152 |
|
|
2014
Q2 | $2.27M | Buy |
26,550
+8,775
| +49% | +$691K | 0.12% | 150 |
|
|
2014
Q1 | $1.4M | Hold |
17,775
| – | – | 0.08% | 179 |
|
|
2013
Q4 | $1.34M | Buy |
17,775
+2,700
| +18% | +$192K | 0.08% | 180 |
|
|
2013
Q3 | $1.05M | Hold |
15,075
| – | – | 0.07% | 185 |
|
|
2013
Q2 | $874K | Buy |
+15,075
| New | +$871K | 0.06% | 195 |
|
Other funds holding IBB
People's United Financial's IBB Position: Q1 2022 in Review
People's United Financial reduced its iShares Biotechnology ETF (IBB) stake by 72% in Q1 2022, selling an estimated $4.86M and leaving 14,490 shares worth $1.89M. The position accounts for 0.05% of the portfolio, ranked #230.
People's United Financial first reported a position in IBB in Q2 2013 and has held it in 35 quarters since. The position peaked at $15.5M in Q2 2021. 898 funds tracked by Wall St. Rank hold IBB as of Q1 2022.
- People's United Financial held 14,490 shares of iShares Biotechnology ETF worth $1.89M as of Q1 2022.
- People's United Financial sold 37,307 iShares Biotechnology ETF shares in Q1 2022, an estimated $4.86M.
- iShares Biotechnology ETF made up 0.05% of People's United Financial's portfolio in Q1 2022, its #230 holding.
- People's United Financial first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 35 quarters since.
- People's United Financial's iShares Biotechnology ETF position peaked at $15.5M in Q2 2021.
- 898 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.